Filing Details
- Accession Number:
- 0000950170-25-011335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-30 21:16:04
- Reporting Period:
- 2025-01-28
- Accepted Time:
- 2025-01-30 21:16:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1812364 | Relay Therapeutics Inc. | RLAY | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1959229 | Peter Rahmer | C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-28 | 1,673 | $4.63 | 307,081 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-01-28 | 139,141 | $0.00 | 446,222 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-01-29 | 26,541 | $4.55 | 419,681 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-30 | 17,250 | $4.42 | 402,431 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 284,033 shares underlying RSUs.
- Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock uponvesting.
- Includes 423,174 shares underlying RSUs.
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 100,000 shares of RSUs on January 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 323,174 shares underlying RSUs.
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 253,604 shares underlying RSUs.
Billionaire Hedge Funds
